Professor Eva Sykova, (M.D., Ph.D, D.Sc.), is the Director of the Institute of Experimental Medicine (IEM) ASCR and an internationally recognized expert in neuroscience and cell therapy. During her directorship the IEM was selected as an EU Centre of Excellence. Since 2000 she has been Professor of Physiology, Head of the National Center for Cell Therapy and Tissue Repair and the Head of the Department of Neuroscience at the IEM ASCR. In 1996 she was also appointed Chairman of the Institute of Neuroscience at Charles University as the founder of that Institute.
Her scientific interests include both basic and clinical research, focusing on neurologic diseases and stem cells, including the role of glial cells in health and disease; the diffusion properties and underlying mechanisms of many pathological states such as neurodegenerative diseases and tumors; spinal cord physiology; the use of biomaterials as tissue bridges, nanofibers as 3D stem cell carriers and nanoparticles for stem cell imaging; the role of stem cells in the rescue and replacement of damaged tissue. In 2008 she founded the Innovative Business Center, which houses business incubators that assist the transfer of results in regenerative medicine research into clinical practice. One of the companies resulting from this center is Bioinova Ltd., which is owned by private investors and the IEM ASCR.
Professor Sykova has published more than 850 scientific publications, including 347 papers in peer-reviewed journals and 39 book chapters. She is the author of one book, the co-editor of four books and co-author of six patents. Her papers have been cited more than 9070 times and her Hirsch index is 51. She serves on the editorial boards of six international journals and also as a member of the executive committees of a number of Czech and international scientific societies and boards. She has been invited to lecture at more than 100 conventions worldwide and has contributed numerous seminars, organized international workshops for young scientists, and participated as an investigator in over than 30 grants and projects.
She has been awarded with 12 scientific awards, most recently the Medal of Merit for meritorious services to state in the field of science. She is an elected member of Academia Europea, the President of the Czech Neuroscience Society and the Czech Society for Gene and Cell Therapy, and serves on six editorial boards of International journals. Prof. Sykova continues to develop and support the emerging field of regenerative medicine and can be considered among the leading Czech scientists dedicated to basic and clinical research of neurodegenerative diseases and stem cell therapy. There are four registered clinical studies running in Czech Republic under her supervision with the products of Bioinova Ltd.